Investing in Lupus
The world’s only venture capital fund dedicated to SLE, backed by the largest private funder of lupus research. The science is ready. The capital is here.
Our Purpose
Our aim is to accelerate the development of new treatments and diagnostics through targeted investment to improve the standard of care and deliver meaningful value to the millions of people living with lupus worldwide. Lupus Ventures was founded by the Lupus Research Alliance in 2026. The Lupus Research Alliance is the world’s largest private funder of lupus research.
Read the Full LetterToday, the landscape is shifting. Scientific understanding is accelerating, regulatory momentum is building, and a rapidly expanding clinical pipeline is redefining what is possible in autoimmune disease. This inflection point is precisely where Lupus Ventures was born.
Nishant Rastogi Managing Director
What We Fund
The Fund has a broad mandate to invest in any technology that has the potential to improve the standard of care and improve quality of life for patients living with lupus, across all stages of development and private financing rounds.
Biotech
Pharma
Diagnostics
Medtech
Digital Health
Others
Our Partnership
Backed by the Lupus Research Alliance
Lupus Ventures is the venture investment fund of the Lupus Research Alliance, the world’s largest private funder of lupus research.
The Lupus Research Alliance has invested over $284 million in lupus research across 675+ research grants.
The clinical affiliate, Lupus Therapeutics, is involved in ~30% of active lupus trials.
About Lupus
Lupus is a chronic, complex autoimmune disease that affects millions of people worldwide. In lupus, the immune system produces autoantibodies that mistake the body’s own cells as foreign, causing other immune cells to attack organs such as the kidneys, brain, heart, lungs, and skin, as well as blood and joints.
December 8, 2025